SCHEMBL15538468

SCHEMBL15538468

O=C(N1CCC(COc2ccc(Br)cc2F)CC1)C1(C(F)(F)F)CCC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
AOC2 O75106 2/20 0.42
MAOB P27338 1/20 0.42
EGFR P00533 5/20 0.41
KDR P35968 5/20 0.41
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
PKM P14618 1/20 0.40
EPHX2 P34913 3/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
MGLL Q99685 3/20 0.38
RBP4 P02753 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15539682 0.84 AOC2 (0.53) L3MBTL1AOC2MAOBPOLBEPHX2
SCHEMBL15538620 0.82 AOC2 (0.47) AOC2MAOBEPHX2PSEN1PSEN2
SCHEMBL16757826 0.81 GPR119 (0.45) AOC2MAOBEPHX2SMN1; SMN2
SCHEMBL19400190 0.81 MAPT (0.47) L3MBTL1EGFRKDRKDM4EPOLB
SCHEMBL15539038 0.80 AOC2 (0.57) L3MBTL1AOC2MAOBPOLBEPHX2
SCHEMBL15539948 0.79 AOC2 (0.45) AOC2MAOBEPHX2PSEN1PSEN2
SCHEMBL15538262 0.78 MAPT (0.39) L3MBTL1EGFRKDRMAPTSMN1; SMN2
SCHEMBL15537604 0.77 GPR119 (0.50) KDM4EPKM
SCHEMBL15549958 0.77 AOC2 (0.47) L3MBTL1AOC2MAOBPOLBEPHX2
SCHEMBL18825480 0.76 MGLL (0.40) AOC2MAOBEPHX2PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 L3MBTL1 4855/4885AOC2 2528/4885MAOB 3220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.